Review Article
Leprosy: A Review of Epidemiology, Clinical Diagnosis, and Management
Table 3
Summarized the treatment regimen recommended from World Health Organization.
| Diagnosis | Population | Medication | Dose | Duration |
| Paucibacillary leprosy | | | | | | Adults | | | | | | Rifampicin | 600 mg/month | 6 months | | | Clofazimine | 300 mg/month + 50 mg/day | 6 months | | | Dapsone | 100 mg/day | 6 months | | Children (10–14 years) | | | | | | Rifampicin | 450 mg/month | 6 months | | | Clofazimine | 150 mg/month + 50 mg/day | 6 months | | | Dapsone | 50 mg/day | 6 months | | Children (<10 years old or <40 kg) | | | | | | Rifampicin | 10 mg/kg/month | 6 months | | | Clofazimine | 6 mg/kg/month + 1 mg/kg/day | 6 months | | | Dapsone | 2 mg/kg/daily | 6 months | Multibacillary leprosy | | | | | | Adult | | | | | | Rifampicin | 600 mg/month | 12 months | | | Clofazimine | 300 mg/month + 50 mg/day | 12 months | | | Dapsone | 100 mg/day | 12 months | | Children (10–14 years) | | | | | | Rifampicin | 450 mg/month | 12 months | | | Clofazimine | 150 mg/month + 50 mg/day | 12 months | | | Dapsone | 50 mg/day | 12 months | | Children (<10 years old or <40 kg | | | | | | Rifampicin | 10 mg/kg/month | 12 months | | | Clofazimine | 6 mg/kg/month + 1 mg/kg/day | 12 months | | | Dapsone | 2 mg/kg/daily | 12 months |
|
|